Suppr超能文献

相互作用组分析显示,C1QBP(补体成分 1,q 亚单位结合蛋白)与癌细胞的趋化性和转移有关。

Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.

机构信息

Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China;

出版信息

Mol Cell Proteomics. 2013 Nov;12(11):3199-209. doi: 10.1074/mcp.M113.029413. Epub 2013 Aug 7.

Abstract

The complement component 1, q subcomponent binding protein (C1QBP/p32/HABP1) is a ubiquitously expressed and multicompartmental cellular protein involved in various biological processes. In order to further understand its biological functions, we conducted proteomics analysis of its interactome in this study. An improved sample preparation and mass spectrometric identification strategy was developed combining high-speed centrifugation, formaldehyde labeling, and two-dimensional reverse-phase liquid chromatography. Using this approach, we identified 187 interacting proteins and constructed a highly connected interacting network for C1QBP. Moreover, we explored the interaction between C1QBP and protein kinase C ζ, a key regulator of cell polarity and migration. The results indicated that C1QBP regulated the activity of protein kinase C ζ and modulated EGF-induced cancer cell chemotaxis. In addition, C1QBP was required for breast cancer metastasis in a severe combined immunodeficiency mouse model. Furthermore, C1QBP was observed to be overexpressed in breast cancer tissues, and its expression level was closely linked with distant metastasis and TNM stages. In summary, C1QBP was identified as a novel regulator of cancer metastasis that may serve as a therapeutic target for breast cancer treatment.

摘要

补体成分 1,q 亚基结合蛋白(C1QBP/p32/HABP1)是一种广泛表达和多区室细胞蛋白,参与多种生物学过程。为了进一步了解其生物学功能,我们在本研究中进行了其互作组的蛋白质组学分析。我们开发了一种改进的样品制备和质谱鉴定策略,结合高速离心、甲醛标记和二维反相液相色谱。使用这种方法,我们鉴定了 187 个相互作用蛋白,并构建了 C1QBP 的高度连接互作网络。此外,我们还探讨了 C1QBP 与蛋白激酶 C ζ 之间的相互作用,蛋白激酶 C ζ 是细胞极性和迁移的关键调节因子。结果表明,C1QBP 调节蛋白激酶 C ζ 的活性并调节 EGF 诱导的癌细胞趋化性。此外,C1QBP 在严重联合免疫缺陷小鼠模型中被发现对乳腺癌转移是必需的。此外,C1QBP 在乳腺癌组织中呈过表达,其表达水平与远处转移和 TNM 分期密切相关。总之,C1QBP 被鉴定为一种新的癌症转移调节剂,可能成为乳腺癌治疗的治疗靶点。

相似文献

引用本文的文献

1
Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis.小细胞外囊泡在胰腺癌进展与诊断中的作用
J Control Release. 2025 Apr 10;380:269-282. doi: 10.1016/j.jconrel.2025.01.072. Epub 2025 Feb 6.
5
gC1qR: A New Target for Cancer Immunotherapy.gC1qR:癌症免疫治疗的新靶点。
Front Immunol. 2023 Jan 26;14:1095943. doi: 10.3389/fimmu.2023.1095943. eCollection 2023.

本文引用的文献

1
Testicular synovial sarcoma: a case report.睾丸滑膜肉瘤:一例报告。
Cancer Biol Med. 2012 Dec;9(4):274-6. doi: 10.7497/j.issn.2095-3941.2012.04.010.
3
Chemotaxis in cancer.癌症中的趋化作用。
Nat Rev Cancer. 2011 Jul 22;11(8):573-87. doi: 10.1038/nrc3078.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验